Stenocare Statistics

Total Valuation

Stenocare has a market cap or net worth of DKK 46.87 million. The enterprise value is 48.07 million.

Market Cap	46.87M
Enterprise Value	48.07M

Important Dates

The next estimated earnings date is Thursday, May 7, 2026.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

Stenocare has 43.20 million shares outstanding. The number of shares has increased by 106.79% in one year.

Current Share Class	43.20M
Shares Outstanding	43.20M
Shares Change (YoY)	+106.79%
Shares Change (QoQ)	+11.63%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	33.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.68
PB Ratio	4.95
P/TBV Ratio	4.95
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-20.11
EV / Sales	6.85
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.49, with a Debt / Equity ratio of 0.21.

Current Ratio	1.49
Quick Ratio	1.19
Debt / Equity	0.21
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.69

Financial Efficiency

Return on equity (ROE) is -79.69% and return on invested capital (ROIC) is -32.96%.

Return on Equity (ROE)	-79.69%
Return on Assets (ROA)	-6.91%
Return on Invested Capital (ROIC)	-32.96%
Return on Capital Employed (ROCE)	-18.72%
Weighted Average Cost of Capital (WACC)	7.67%
Revenue Per Employee	877,625
Profits Per Employee	-298,816
Employee Count	8
Asset Turnover	0.44
Inventory Turnover	18.51

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +239.62% in the last 52 weeks. The beta is 0.48, so Stenocare's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	+239.62%
50-Day Moving Average	1.15
200-Day Moving Average	1.28
Relative Strength Index (RSI)	51.25
Average Volume (20 Days)	170,297

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Stenocare had revenue of DKK 7.02 million and -2.39 million in losses. Loss per share was -0.06.

Revenue	7.02M
Gross Profit	1.22M
Operating Income	-1.77M
Pretax Income	-2.39M
Net Income	-2.39M
EBITDA	-1.70M
EBIT	-1.77M
Loss Per Share	-0.06

Full Income Statement

Balance Sheet

The company has 787,400 in cash and 1.99 million in debt, giving a net cash position of -1.20 million or -0.03 per share.

Cash & Cash Equivalents	787,400
Total Debt	1.99M
Net Cash	-1.20M
Net Cash Per Share	-0.03
Equity (Book Value)	9.47M
Book Value Per Share	0.22
Working Capital	1.54M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-7.20M
Capital Expenditures	n/a
Depreciation & Amortization	69,759
Net Borrowing	-1.09M
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 17.42%, with operating and profit margins of -25.26% and -34.05%.

Gross Margin	17.42%
Operating Margin	-25.26%
Pretax Margin	-34.05%
Profit Margin	-34.05%
EBITDA Margin	-24.27%
EBIT Margin	-25.26%
FCF Margin	n/a

Dividends & Yields

Stenocare does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-106.79%
Shareholder Yield	-106.79%
Earnings Yield	-5.10%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Stenocare has an Altman Z-Score of 6.83 and a Piotroski F-Score of 3.

Altman Z-Score	6.83
Piotroski F-Score	3